METHUSELAH ARCHIVE / FRAMEWORKS / WOOTTON-SPURIOUS-BIOMARKER-PATTERN

The spurious-biomarker pattern: Wright's opsonin index as historical type-specimen

framework · David Wootton
"Fleming thus made a very good living out of selling what were, in effect, sophisticated quack remedies."
Wootton, Bad Medicine (Oxford University Press, 2006), p. 244 (on Sir Almroth Wright's Inoculation Department at St Mary's Hospital and Fleming's role in it).
SUMMARY
Wootton's analysis of Sir Almroth Wright's vaccine business at St Mary's Hospital identifies the structural pattern that this framework names the spurious-biomarker pattern. Wright invented and patented the opsonin index, a laboratory measurement of patient blood that was claimed to track immune response to bacterial vaccines, and used it as the basis for individualized vaccine prescription and treatment monitoring. The opsonin index was the operational pretext for the entire commercial vaccine practice: the index allowed Wright and his Inoculation Department to sell repeat consultations and serial vaccine doses on the grounds that the laboratory test demonstrated patient-specific need and patient-specific response. The opsonin index has been independently shown to be a measurement of methodological artefact rather than of clinically relevant immune response, and the underlying vaccine practice produced no demonstrated clinical benefit beyond placebo. The pattern (invented biomarker, laboratory measurement, individualized prescription, repeat-purchase revenue model, no clinical-endpoint demonstration) is the direct historical analogue of the contemporary epigenetic-clock (GrimAge, DunedinPACE, Horvath, Hannum) market. Wootton's reading of the Wright case is presented in *Bad Medicine* as a single paragraph (p. 244) with the principal historical detail derived from Wai Chen's 1992 chapter; the archive's independent treatment is gated on direct reading of Chen 1992.
APPLIES TO CASES
APPLIES TO INTERVENTIONS
SOURCES
NOTES

The spurious-biomarker pattern is the framework with the most direct application to contemporary elite-longevity practice. The pattern’s structural features are: (1) the practitioner or practitioner organization develops or adopts a laboratory measurement whose validity as a surrogate for a hard clinical endpoint is asserted rather than demonstrated; (2) the measurement becomes the operational basis for individualized prescription, repeat consultation, and ongoing treatment monitoring; (3) the measurement’s movement under intervention is then cited as evidence of clinical benefit, in lieu of a hard-endpoint demonstration; (4) the entire commercial practice rests on the cycle of measure, prescribe, re-measure, re-prescribe; (5) attempts to demonstrate that movement on the surrogate corresponds to movement on the hard endpoint are either not undertaken, fail, or are under-powered. The TPE-IVIG protocol’s reliance on epigenetic-clock surrogates (GrimAge, DunedinPACE) for the demonstration of ‘biological-age reversal’ is the archive’s modern type-specimen of the pattern, and is structurally indistinguishable from Wright’s opsonin-index-driven vaccine practice c. 1900 to 1946. The framework’s predictive utility is operational: when a contemporary intervention’s principal evidence base is movement on a proprietary or contested surrogate biomarker, with no published hard-endpoint demonstration and a commercial revenue model that depends on repeat biomarker measurement, the archive’s standing prediction is that the intervention will not, on adequately powered hard-endpoint trial, be shown to extend life or to reduce age-related morbidity beyond placebo. The Chen 1992 chapter, listed here as a source, has not yet been directly read by the archive’s research team; the citation is derived from Wootton’s bibliography and from standard library catalog metadata, and the framework’s reading of the Wright case is gated for independent corroboration on direct reading of Chen.”